Detection of germline variants in Brazilian breast cancer patients using multigene panel testing
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Detection of germline variants in Brazilian breast cancer patients using multigene panel testing
Authors
Keywords
-
Journal
Scientific Reports
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-09
DOI
10.1038/s41598-022-07383-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women
- (2021) et al. NEW ENGLAND JOURNAL OF MEDICINE
- BARD1 Pathogenic Variants are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort
- (2021) Paula Rofes et al. Genes
- Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis
- (2021) Renata Lazari Sandoval et al. PLoS One
- Prevalence and Clinicopathological Characteristics of Moderate and High-Penetrance Genes in Non-BRCA1/2 Breast Cancer High-Risk Spanish Families
- (2021) Maria Fonfria et al. Journal of Personalized Medicine
- Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population
- (2020) Simone da Costa e Silva Carvalho et al. BMC Medical Genomics
- Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers
- (2020) Wejdan M. Alenezi et al. Genes
- XAF1 as a modifier of p53 function and cancer susceptibility
- (2020) Emilia M. Pinto et al. Science Advances
- Clinical and psychological outcomes of receiving a variant of uncertain significance from multigene panel testing or genomic sequencing: a systematic review and meta-analysis
- (2020) Chloe Mighton et al. GENETICS IN MEDICINE
- Germline variants of Brazilian women with breast cancer and detection of a novel pathogenic ATM deletion in early-onset breast cancer
- (2020) Gabriel Bandeira et al. Breast Cancer
- [PROVISIONAL] A systematic scoping review of the genetic ancestry of the Brazilian population
- (2019) Aracele Maria de Souza et al. GENETICS AND MOLECULAR BIOLOGY
- Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
- (2018) Timothy R. Rebbeck et al. HUMAN MUTATION
- Somatic mutations in early onset luminal breast cancer
- (2018) Giselly Encinas et al. Oncotarget
- The germline mutational landscape of BRCA1 and BRCA2 in Brazil
- (2018) Edenir Inêz Palmero et al. Scientific Reports
- Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer
- (2018) Allison W. Kurian et al. JAMA Oncology
- A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer
- (2018) Ana Rafaela de Souza Timoteo et al. BREAST CANCER RESEARCH AND TREATMENT
- Elucidating the Underlying Functional Mechanisms of Breast Cancer Susceptibility Through Post-GWAS Analyses
- (2018) Mahdi Rivandi et al. Frontiers in Genetics
- Variable population prevalence estimates of germline TP53 variants: A gnomAD-based analysis
- (2018) Kelvin C. de Andrade et al. HUMAN MUTATION
- Mutation screening of TP53, CHEK2 and BRCA genes in patients at high risk for hereditary breast and ovarian cancer (HBOC) in Brazil
- (2018) Nilson Moreira Cipriano et al. Breast Cancer
- BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
- (2017) Bárbara Alemar et al. PLoS One
- Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil
- (2016) Edenir Inêz Palmero et al. GENETICS AND MOLECULAR BIOLOGY
- Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care
- (2016) Ella R. Thompson et al. JOURNAL OF CLINICAL ONCOLOGY
- Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer
- (2016) Nadine Tung et al. JOURNAL OF CLINICAL ONCOLOGY
- PALB2,CHEK2andATMrare variants and cancer risk: data from COGS
- (2016) Melissa C Southey et al. JOURNAL OF MEDICAL GENETICS
- Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry
- (2016) Gabriela C. Fernandes et al. Oncotarget
- The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective
- (2015) Julie Dutil et al. BREAST CANCER RESEARCH AND TREATMENT
- Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
- (2015) Douglas F. Easton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multigene Panel Testing in Oncology Practice
- (2015) Allison W. Kurian et al. JAMA Oncology
- Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment
- (2015) Andrea Desmond et al. JAMA Oncology
- Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients
- (2014) Felipe C Silva et al. BMC Medical Genetics
- Frequency of mutations in individuals with breast cancer referred forBRCA1andBRCA2testing using next-generation sequencing with a 25-gene panel
- (2014) Nadine Tung et al. CANCER
- Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland
- (2014) C. Cybulski et al. CLINICAL GENETICS
- Risk of Colorectal Cancer for Carriers of Mutations in MUTYH, With and Without a Family History of Cancer
- (2014) Aung Ko Win et al. GASTROENTEROLOGY
- Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients
- (2014) Holly LaDuca et al. GENETICS IN MEDICINE
- Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer
- (2014) Kara N. Maxwell et al. GENETICS IN MEDICINE
- Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment
- (2014) Allison W. Kurian et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevalence of the TP53 p.R337H Mutation in Breast Cancer Patients in Brazil
- (2014) Juliana Giacomazzi et al. PLoS One
- Impact of Neonatal Screening and Surveillance for the TP53 R337H Mutation on Early Detection of Childhood Adrenocortical Tumors
- (2013) Gislaine Custódio et al. JOURNAL OF CLINICAL ONCOLOGY
- Large-scale genotyping identifies 41 new loci associated with breast cancer risk
- (2013) Kyriaki Michailidou et al. NATURE GENETICS
- Comprehensive Analysis of BRCA1, BRCA2 and TP53 Germline Mutation and Tumor Characterization: A Portrait of Early-Onset Breast Cancer in Brazil
- (2013) Dirce Maria Carraro et al. PLoS One
- BRCA in breast cancer: ESMO Clinical Practice Guidelines
- (2011) J. Balmana et al. ANNALS OF ONCOLOGY
- Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil
- (2009) V.F. Esteves et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening?
- (2009) Maria Isabel Waddington Achatz et al. LANCET ONCOLOGY
- Association of the germline TP53R337H mutation with breast cancer in southern Brazil
- (2008) Juliana G Assumpção et al. BMC CANCER
- Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil
- (2008) Edenir Inêz Palmero et al. CANCER LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started